Jci_page_head_homepage_01 Jci_page_head_homepage_02
Birgit Liliensiek, Markus A. Weigand, Angelika Bierhaus, Werner Nicklas, Michael Kasper, Stefan Hofer, Jens Plachky, Herman-Josef Gröne, Florian C. Kurschus, Ann Marie Schmidt, Shi Du Yan, Eike Martin, Erwin Schleicher, David M. Stern, Günter J. Hämmerling, Peter P. Nawroth, Bernd Arnold
Published in Volume 113, Issue 11
J Clin Invest. 2004; 113(11):1641–1650 doi:10.1172/JCI18704
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

NF-κB inducibility in peripheral blood mononuclear cells of the various mouse strains. Six-month-old WT, RAGE–/–, Tie2RAGE, or Tie2RAGE ∞ RAGE–/– mice received unmodified control hemoglobin (Contr.-Hg) or CML-modified hemoglobin (CML-Hg) (1,000 ∝g/mouse at time point 0, intraperitoneally). Six days later, mice were sacrificed and NF-κB–binding activity was determined in total blood. Recombinant NF-κB (Rec. NF-κB) produced in erythrocyte lysates served as control for NF-κB binding. To confirm NF-κB binding, binding activity at 6 days was competed with a 160-fold molar excess of unlabeled consensus NF-κB oligonucleaotides (cons.). Arrowheads indicate NF-κB complexes consisting of NF-κB homodimers or NF-κB (p50/p65) heterodimers, respectively.